Mineralocorticoid receptors in the ventral tegmental area regulate dopamine efflux in the basolateral amygdala during the expression of conditioned fear

Psychoneuroendocrinology

Volumn 43, Issue , 2014, Pages 114-125

  De Oliveira, Amanda R ^a,b   Reimer, Adriano E ^a,b   Brandão, Marcus L ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Campus USP   (Brazil)

Author keywords

Basolateral amygdala complex; Dopamine; Fear conditioning; Glucocorticoid receptors; Mineralocorticoid receptors; Ventral tegmental area

Indexed keywords

DOPAMINE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; CONDITIONING; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; FEAR; FREEZING; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VIVO STUDY; MALE; MICRODIALYSIS; MOTOR PERFORMANCE; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY; VENTRAL TEGMENTUM; AMYGDALOID NUCLEUS; ANIMAL; DRUG EFFECTS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; PSYCHOLOGY; WISTAR RAT;

AMYGDALA; ANIMALS; CONDITIONING (PSYCHOLOGY); DOPAMINE; FEAR; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE; VENTRAL TEGMENTAL AREA;

EID: 84897437891     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.02.010     Document Type: Article

References (52)

1. Albrechet-Souza L., Carvalho M.C., Franci C.R., Brandão M.L. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Horm. Behav. 2007, 52:267-273.
2. Barr G.A., Moriceau S., Shionoya K., Muzny K., Gao P., Wang S., Sullivan R.M. Transitions in infant learning are modulated by dopamine in the amygdala. Nat. Neurosci. 2009, 12:1367-1369.
3. Bonci A., Malenka R.C. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J. Neurosci. 1999, 19:3723-3730.
4. Conrad C.D., MacMillan D.D., Tsekhanov S., Wright R.L., Baran S.E., Fuchs R.A. Influence of chronic corticosterone and glucocorticoid receptor antagonism in the amygdala on fear conditioning. Neurobiol. Learn. Mem. 2004, 81:185-199.
5. Cordero M.I., Merino J.J., Sandi C. Correlational relationship between shock intensity and corticosterone secretion on the establishment and subsequent expression of contextual fear conditioning. Behav. Neurosci. 1998, 112:885-891.
6. de Kloet E.R., Karst H., Joels M. Corticosteroid hormones in the central stress response: quick-and-slow. Front. Neuroendocrinol. 2008, 29:268-272.
7. de Oliveira A.R., Reimer A.E., Brandao M.L. Dopamine D2 receptor mechanisms in the expression of conditioned fear. Pharmacol. Biochem. Behav. 2006, 84:102-111.
8. de Oliveira A.R., Reimer A.E., Brandao M.L. Role of dopamine receptors in the ventral tegmental area in conditioned fear. Behav. Brain. Res. 2009, 199:271-277.
9. de Oliveira A.R., Reimer A.E., de Macedo C.E., de Carvalho M.C., Silva M.A., Brandao M.L. Conditioned fear is modulated by D2 receptor pathway connecting the ventral tegmental area and basolateral amygdala. Neurobiol. Learn. Mem. 2011, 95:37-45.
10. de Oliveira A.R., Reimer A.E., Reis F.M., Brandao M.L. Conditioned fear response is modulated by a combined action of the hypothalamic-pituitary-adrenal axis and dopamine activity in the basolateral amygdala. Eur. Neuropsychopharmacol. 2013, 23:379-389.
11. de Souza Caetano K.A., de Oliveira A.R., Brandao M.L. Dopamine D2 receptors modulate the expression of contextual conditioned fear: role of the ventral tegmental area and the basolateral amygdala. Behav. Pharmacol. 2013, 24:264-274.
12. Fadok J.P., Dickerson T.M., Palmiter R.D. Dopamine is necessary for cue-dependent fear conditioning. J. Neurosci. 2009, 29:11089-11097.
13. Gaillard R.C., Riondel A., Muller A.F., Herrmann W., Baulieu E.E. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:3879-3882.
14. Harfstrand A., Fuxe K., Cintra A., Agnati L.F., Zini I., Wikstrom A.C., Okret S., Yu Z.Y., Goldstein M., Steinbusch H., et al. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:9779-9783.
15. Houlihan D.J. Psychostimulant treatment of combat-related posttraumatic stress disorder. J. Psychopharmacol. 2011, 25:1568-1572.
16. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur. J. Pharmacol. 1989, 165:337-338.
17. Indovina I., Robbins T.W., Nunez-Elizalde A.O., Dunn B.D., Bishop S.J. Fear-conditioning mechanisms associated with trait vulnerability to anxiety in humans. Neuron 2011, 69:563-571.
18. Joels M., Karst H., DeRijk R., de Kloet E.R. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008, 31:1-7.
19. Johnson L.R., Farb C., Morrison J.H., McEwen B.S., LeDoux J.E. Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala. Neuroscience 2005, 136:289-299.
20. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 1992, 450:455-468.
21. Katzman M.A. Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness. J. Affect. Disord. 2011, 128(Suppl. 1):S11L 20.
22. Korte S.M., de Boer S.F., de Kloet E.R., Bohus B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 1995, 20:385-394.
23. LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol. Neurobiol. 2003, 23:727-738.
24. Lu N.Z., Wardell S.E., Burnstein K.L., Defranco D., Fuller P.J., Giguere V., Hochberg R.B., McKay L., Renoir J.M., Weigel N.L., Wilson E.M., McDonnell D.P., Cidlowski J.A. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol. Rev. 2006, 58:782-797.
25. Lupien S.J., McEwen B.S. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res. Brain Res. Rev. 1997, 24:1-27.
26. Maren S., Fanselow M.S. The amygdala and fear conditioning: has the nut been cracked?. Neuron 1996, 16:237-240.
27. Marin M.F., Hupbach A., Maheu F.S., Nader K., Lupien S.J. Metyrapone administration reduces the strength of an emotional memory trace in a long-lasting manner. J. Clin. Endocrinol. Metab. 2011, 96:E1221-E1227.
28. Martinez R.C., Oliveira A.R., Macedo C.E., Molina V.A., Brandao M.L. Involvement of dopaminergic mechanisms in the nucleus accumbens core and shell subregions in the expression of fear conditioning. Neurosci. Lett. 2008, 446:112-116.
29. McEwen B.S., Weiss J.M., Schwartz L.S. Uptake of corticosterone by rat brain and its concentration by certain limbic structures. Brain Res. 1969, 16:227-241.
30. Ninomiya E.M., Martynhak B.J., Zanoveli J.M., Correia D., da Cunha C., Andreatini R. Spironolactone and low-dose dexamethasone enhance extinction of contextual fear conditioning. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:1229-1235.
31. Orchinik M., Murray T.F., Moore F.L. A corticosteroid receptor in neuronal membranes. Science 1991, 252:1848-1851.
32. Otte C., Moritz S., Yassouridis A., Koop M., Madrischewski A.M., Wiedemann K., Kellner M. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology 2007, 32:232-238.
33. Pare D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. J. Neurophysiol. 2004, 92:1-9.
34. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition 2007, Elsevier Science, Amsterdam. 6th ed.
35. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005, 48:175-187.
36. Ratka A., Sutanto W., Bloemers M., de Kloet E.R. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 1989, 50:117-123.
37. Reis F.L., Masson S., de Oliveira A.R., Brandao M.L. Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests. Pharmacol. Biochem. Behav. 2004, 79:359-365.
38. Reis F.M., Albrechet-Souza L., Franci C.R., Brandao M.L. Risk assessment behaviors associated with corticosterone trigger the defense reaction to social isolation in rats: role of the anterior cingulate cortex. Stress 2012, 15:318-328.
39. Reul J.M., de Kloet E.R. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J. Steroid Biochem. 1986, 24:269-272.
40. Rimmele U., Besedovsky L., Lange T., Born J. Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. Neuropsychopharmacology 2013, 38:884-894.
41. Rivet J.M., Stinus L., LeMoal M., Mormede P. Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res. 1989, 498:149-153.
42. Rodrigues S.M., LeDoux J.E., Sapolsky R.M. The influence of stress hormones on fear circuitry. Annu. Rev. Neurosci. 2009, 32:289-313.
43. Ronken E., Mulder A.H., Schoffelmeer A.N. Glucocorticoid and mineralocorticoid receptors differentially modulate cultured dopaminergic neurons of rat ventral mesencephalon. Eur. J. Pharmacol. 1994, 263:149-156.
44. Roozendaal B., McGaugh J.L. Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage. Neurobiol. Learn. Mem. 1997, 67:176-179.
45. Sapolsky R. Any kind of mother in a storm. Nat. Neurosci. 2009, 12:1355-1356.
46. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci. 1990, 13:359-362.
47. Spiga F., Knight D.M., Droste S.K., Conway-Campbell B., Kershaw Y., MacSweeney C.P., Thomson F.J., Craighead M., Peeters B.W., Lightman S.L. Differential effect of glucocorticoid receptor antagonists on glucocorticoid receptor nuclear translocation and DNA binding. J. Psychopharmacol. 2011, 25:211-221.
48. Stevens W., Grosser B.I., Reed D.J. Corticosterone-binding molecules in rat brain cytosols: regional distribution. Brain Res. 1971, 35:602-607.
49. Tasker J.G., Di S., Malcher-Lopes R. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 2006, 147:5549-5556.
50. Yang Y.L., Chao P.K., Lu K.T. Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 2006, 31:912-924.
51. Yoshioka M., Matsumoto M., Togashi H., Saito H. Effect of conditioned fear stress on dopamine release in the rat prefrontal cortex. Neurosci. Lett. 1996, 209:201-203.
52. Zweifel L.S., Fadok J.P., Argilli E., Garelick M.G., Jones G.L., Dickerson T.M., Allen J.M., Mizumori S.J., Bonci A., Palmiter R.D. Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety. Nat. Neurosci. 2011, 14:620-626.